Jorge DiMartino
College of San Mateo(US)Plex Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Protein Degradation and Inhibitors, Epigenetics and DNA Methylation, Chronic Myeloid Leukemia Treatments, Cancer-related Molecular Pathways
Most-Cited Works
- → The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia(2018)450 cited
- → Microenvironment Determines Lineage Fate in a Human Model of MLL-AF9 Leukemia(2008)318 cited
- → MLL rearrangements in haematological malignancies: lessons from clinical and biological studies(1999)262 cited
- → The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver(2001)172 cited
- → The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10(2002)134 cited
- → A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL(2000)102 cited